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The interaction of novel diacylglycerol analogues at the recognition site on protein kinase C has been evaluated using 
a modified PH]phorbol dibutyrate binding assay and an established kinase activation assay. Studies with the 3-methyl 
analogues of 1,2-dihexanoyl-sn-glycerol have revealed a preferred stereochemical configuration at the C-3 position. Other 
chemical modifications have extended existing structure/activity relationships by showing that carbamates and sulphonyl 
esters cannot substitute for carboxylate esters and that cyclic acyl groups are active. Thus, most, if not all of the function- 
alities in the diacylglycerol molecule are required for interaction at the receptor on protein kinase C. Stereochemical speci- 
ficity is required at C2 and C3. 
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1. INTRODUCTION 
Diacylglycerol (DAG) generated from phospha- 
tidylinositol 4,5bisphosphate hydrolysis within 
the plasma membrane activates protein kinase C 
(PKC) through an interaction that has character- 
istics of a ligand-receptor interaction [l-3]. Fur- 
thermore, the receptor on PKC for DAG is also the 
receptor for certain phorbol esters, such as phor- 
bol lZmyristate-13-acetate (PMA) and phorbol 
12,13-dibutyrate (PDBu). Understanding of the 
role of PKC in cellular control would be improved 
by refinement of the chemical tools with which to 
either stimulate or, more importantly, inhibit this 
enzyme. 
To date only four publications have described in 
detail the structural requirements for activators of 
PKC. Ganong et al. [4], Boni and Rando [5] and 
Kerr and co-workers [6] focused on the structural 
requirements of DAGs for activation, while 
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Wender et al. [7] used computer modelling tech- 
niques in an attempt o identify structural features 
common to PKC-activating natural products. Our 
aim has been to investigate further the structural 
features of the DAG molecule that confer affinity 
for the DAG binding site and efficacy for PKC ac- 
tivation. 
This report extends current understanding of the 
structure/activity relationships for activation of 
PKC by DAGs and describes a second chiral centre 
in DAG-related molecules that defines further the 
stereochemical configuration necessary for interac- 
tion at the receptor on PKC. 
2. MATERIALS AND METHODS 
PKC was partially purified by a procedure based on the 
method of Niedel et al. [8] and was assayed using the method 
described by Hannun et al. [9,10] which induced the following 
modifications: phosphatidylserine (PS) in the Triton X-100 
mixed lipid micelles was increased to 20 mol%, histone 111s was 
added at I mg/ml and the free calcium concentration was buf- 
fered at 1OOpM [II]. 
[3H]PDBu binding was measured using the PS/Triton X-100 
mixed micelle system described previously [12]. A rapid filtering 
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technique was developed in which PKC, its associated ligand 
and PS/Triton X-100 mixed micelles were bound to a beaded 
anion exchanger (DE52, Whatman) prior to filtration through 
a GF/C filter. DE52, supplied pre-swollen, was washed exten- 
sively in the assay buffer prior to use. The final concentration 
of [‘H]PDBu was 10 nM, PS was used at 20 mol% and non- 
specific binding was assessed in the presence of 1OpM unla- 
belled PDBu. 
2.1. Chemical synthesis 
(R)-4-Acetyl-2,2-dimethyl-1,3-dioxolane was prepared from 
methyl cY,,&isopropylidene-L-glycerate (Fluka) by the method 
described [13] for the (S’)-enantiomer. Reduction with lithium 
aluminium hydride gave a mixture of epimeric alcohols which 
on sequential benzylation [14], deketalisation [14] and dihex- 
anoylation [15] produced a mixture of epimeric 3-benzyloxy- 
1,2-dihexanoyloxybutanes. These diesters were separated by 
flash chromatography, eluting with a mixture of ether and 
hexane (1: 7). The faster running component was characterised 
and debenzylated [15] to give pure 2-(R)-hexanoyloxy-3-(S)- 
hydroxybutyl hexanoate (I, see fig.2). The slower running 
diester similarly gave the 2(R),3(R)-isomer (II, fig.2). The 
2(X),3(R)- and 2(S),3(S)-isomers (III and IV, respectively, fig.2) 
were prepared exactly as described above starting with cu,,B- 
isopropylidene-D-glycerate. Other glycerol derivatives were 
prepared essentially by the methods described previously [15]. 
All products and intermediates were shown to be 
homogeneous by thin-layer chromatography, exhibited 
200 MHz NMR spectra consistent with the proposed structures, 
and gave satisfactory microanalyses for carbon, hydrogen and, 
where appropriate, nitrogen. 
2.2. Materials 
PS was supplied by Lipid Products, England as the sodium 
salt. Leupeptin and PDBu were from Sigma and EGTA (Puriss 
grade) was obtained from Fluka. All other reagents were of 
analytical grade. 
3. RESULTS 
A series of novel diacylglycerols largely based on 
the structure of the cell-permeant compounds 
dihexanoylglycerol and dioctanoylglycerol [ 16- 
201, were synthesized and tested in the two assay 
systems. 1,2-Dihexanoyl-sn-glycerol had at least 
lo-fold greater affinity than its enantiomer, 
2,3-dihexanoyl-sn-glycerol, or the positional iso- 
mer, 1,3-dihexanoylglycerol (fig. IA). The require- 
ment for a 1,2-diacyl-sn-glycerol configuration 
was also evident from the PKC activation data, the 
enantiomer and the positional isomer being 
approx. 50 times less potent than 1,2-dihexanoyl- 
sn-glycerol (fig.lB). The stereochemical require- 
ments for interaction at the recognition site were 
further explored by substituting methyl groups for 
the hydrogen atoms at the 3 position in 1,2-dihex- 
anoyl-sn-glycerol. This chemical modification 
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Fig.1. (A) Displacement of [‘H]PDBu from PKC by 
diacylglycerol analogues. (B) Activation of PKC by diacyl- 
glycerol analogues. Data are expressed as a percentage of the 
response stimulated by a saturating concentration of PDBu. PS 
and Ca2+-dependent kinase activity was stimulated 335 f 12% 
(mean ? SE of 10 determinations) by lOaM PDBu. (0) 
1,2-Dihexanoyl-sn-glycerol; (0) epimer I; (A) 2,3-dihexanoyl- 
sn-glycerol; (A) 1,3-dihexanoylglycerol; (a) epimer II. All 
results are the mean +- SE of three separate determinations. 
yields two epimers differing in configuration at the 
3 position (fig.2, I and II). Epimer I had an EDso 
for activation of PKC of 0.1 mol%, which is 
almost 50 times less than the EDso for epimer II 
(see fig.lB). This difference in potency was re- 
flected in the significant difference in the affinities 
of the epimers for the PDBu binding site (fig.lA). 
Epimer I displaced [3H]PDBu with an I& value 
of 0.8 mol% whereas epimer II displaced only 
25% of the total [3H]PDBu at 10 mol%. 
The set of methyl substituted diacyl compounds 
was completed by preparing the epimeric pair III 
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Fig.2. The 3-methyl isomers of dihexanoyl-sn-glycerol. I, 2-(R)- 
hexanoyloxy-3-(S)-hydroxybutyl hexanoate; II, 2-(R)-hexanoyl- 
oxy-3-(R)-hydroxybutyl hexanoate; III, 2-(S)-hexanoyloxy-3- 
(R)-hydroxybutyl hexanoate; IV, 2-(S)-hexanoyloxy-3-(S)-hy- 
droxybutyl hexanoate. 
and IV (see fig.2), which are mirror images of I 
and II, respectively, and have the unnatural 
stereochemistry at position 2. Epimers III and IV 
were very weak activators of PKC and had low af- 
finity at the phorbol ester receptor displacing ap- 
prox. 25% of the specifically bound [3H]PDBu at 
10 mol%. 
A number of compounds with similar lipid 
solubility (calculated log P values) to 1,2-dihexa- 
noyl-sn-glycerol were synthesized in order to probe 
the requirements for bulk and flexibility in the acyl 
chains independently from the demands for lipo- 
philicity. Increasing the bulk and restricting the 
movement of the chains in cyclohexyl or cyclopen- 
tyl rings had no effect on either affinity or ef- 
ficacy. Introduction of a phenyl group reduced the 
ability to activate PKC and slightly decreased af- 
finity. However, this was largely overcome by in- 
cluding an extra methylene group between the ring 
and the glycerol backbone (not shown). It appears 
that the affinity and efficacy of these compounds 
is governed more by their lipophilicity than by the 
bulk and flexibility of the acyl chains. For exam- 
ple, compounds in which a methylene group in the 
acyl chain was replaced by an ether-linked oxygen 
did not displace [3H]PDBu at concentrations up to 
10 mol% and failed to activate PKC (not shown). 
Replacing the carboxylate ester moieties at posi- 
tions 1 and 2 with carbamoyl groups or sulphonyl 
esters caused a significant drop in affinity and ef- 
ficacy. Substituting only one of the carboxylate 
ester groups at either position 1 or 2 with a car- 
bamoyl or sulphonyl moiety also resulted in a 
dramatic loss of potency in both assay systems (not 
shown). Eliminating the hydroxyl group at posi- 
tion 3 yielded an inactive compound which failed 
to displace [3H]PDBu or activate PKC even at high 
concentrations (not shown). Likewise, substituting 
an aldehyde function at this position also produced 
a compound that had no activity in the two assay 
systems. 
4. DISCUSSION 
This report forms part of a continuing investiga- 
tion of the structural requirements for interaction 
at the DAG site on PKC. Inherent in this study, as 
in others, is the assumption that the relevant 
recognition sites behave the same in detergent/ 
lipid micelles as in the phospholipid bilayer of 
plasma membranes. The histone phosphorylation 
assay was characterised in detail to obtain op- 
timum conditions for measuring DAG-stimulated 
kinase activity. The optimum concentration of PS 
was 20 mol%, rather than 10 mol% as reported by 
Hannun et al. [10,12]: in our hands PS at 10 mol% 
supported only a very small degree of kinase activi- 
ty. Nevertheless, the rank order of potency of the 
short-chain DAGs agrees exactly with published 
reports [18,20] although the concentration-effect 
curves for activation of PKC are to the left of 
those reported previously [lo]. The structural re- 
quirements for PKC activators derived from 
isolated enzyme studies [4,5], have been confirmed 
by investigations using whole cells [ 18-241. Clearly 
the interaction of DAGs with PKC in cell mem- 
branes can be reproduced in the PWTriton mixed 
micelle assay. 
Analysis of the [3H]PDBu binding assay used in 
this study indicated that association of the enzyme 
with DEAE cellulose did not affect the binding 
parameters, the apparent Kd (12 nM) and the time 
course of [3H]PDBu binding (not shown) being 
very close to those observed previously [12]. Fur- 
thermore, the displacement of [3H]PDBu by DAG 
displayed the stereospecificity seen in the histone 
phosphorylation assay (fig.lA and B and [5,231) 
and in DAG stimulation of whole cells [21,22]. The 
lo-fold greater affinity of the 1,2-diacyl-s& 
enantiomer is exactly that observed in whole HL60 
cells (Thompson, N.T., unpublished). 
The novel structural modifications made to the 
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DAG molecule described here have provided fur- 
ther insight into the requirements for affinity, but 
at present these are indistinguishable from the re- 
quirements for efficacy. Analysis of the two pairs 
of diastereoisomers (I-IV, fig.2) has extended our 
understanding of the stereochemical requirements 
for interaction with the recognition site on PKC. 
In addition to the need for a natural 1,2-diacyl-sn- 
glycerol configuration [5,21-231 there is a pre- 
ferred stereochemical arrangement at the 3 posi- 
tion in the methylated analogues. Future analysis 
of the l-methyl isomers will help further to define 
the absolute stereochemical configuration of 
DAG-like PKC activators. This study also con- 
firms and extends a number of the structural 
features required for interaction at the DAG recep- 
tor on PKC. Carbamates and sulphonyl esters can- 
not substitute for carboxylate esters, furthermore, 
alkyl substitutions at either Cl or C2 also resulted 
in a loss of activity, supporting the conclusion that 
both carbonyl functions are necessary for full 
potency [4]. There is an absolute requirement for 
a 3-hydroxyl moiety [4]. Replacing the hydroxyl 
group with an aldehyde function does not restore 
either affinity or efficacy, suggesting that the 
primary hydroxyl group is hydrogen-bond 
donating. There is clearly a strict requirement for 
lipophilicity in the acyl chain; a compound which 
contains an oxygen atom in the middle of the chain 
is significantly less lipophilic than 1 ,Zdihexanoyl- 
sn-glycerol and was devoid of activity. We have no 
evidence to suggest hat this lack of activity was 
due to the compound being unable to form mixed 
lipid micelles. Using the PS/Triton mixed micelle 
assay Hannun et al. [lo] showed that DAGs with 
acyl chains containing 8 or more carbon atoms 
were the most potent activators of PKC. Our in- 
vestigation extends this observation by showing 
that both affinity and efficacy are relatively in- 
dependent of the bulk and electronic properties of 
the acyl chains. 
Thus, it is apparent that effective interaction 
between DAG and the recognition site on PKC re- 
quires all of the chemical functionalities of the 
DAG molecule and a more precise stereochemical 
configuration than has been described before. 
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